Blueberries Medical Signs Framework Agreement with YVY Life Sciences of Uruguay March 26, 2021 09:01 ET | Source: Blueberries Medical Corp. Blueberries Medical Corp. Richmond, British Columbia, CANADA TORONTO, March 26, 2021 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S., the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “ Company” or “ Blueberries”), today announced that it has signed a Framework Agreement with Mechelen S.A., a subsidiary of YVY Life Sciences (“ YVY”) for mutual development of strains and genetics in Colombia and potentially exporting dry cannabis flower of mutual strains from Uruguay.